Impact of cutaneous bioavailability in local skin toxicity: Preliminary results from cosmetics Europe skin bioavailability and metabolism task force
Sebastien Grégoire(L'Oréal (France)), Amy L. Roe(Procter & Gamble (United States)), Andreas Schepky(Beiersdorf (Germany)), Carine Jacques(Pierre Fabre (France)), Joan Eilstein(L'Oréal (France)), Martina Klarić(Cosmetics Europe), N. Hewitt(Cosmetics Europe), Helga Rothe(Procter & Gamble (Germany)), Daniela Lange(MSB Medical School Berlin), Corie A. Ellison(Procter & Gamble (United States)), Richard Cubberley(Unilever (United Kingdom))
Cited by 0
Related Papers
Effective exposure of chemicals in in vitro cell systems: A review of chemical distribution models
|Toxicology in Vitro|2021|127
Imaging the distribution of skin lipids and topically applied compounds in human skin using mass spectrometry
|Scientific Reports|2018|108
Measurement of the penetration of 56 cosmetic relevant chemicals into and through human skin using a standardized protocol
|Journal of Applied Toxicology|2019|72
Partition coefficient and diffusion coefficient determinations of 50 compounds in human intact skin, isolated skin layers and isolated stratum corneum lipids
|Toxicology in Vitro|2020|66
Imaging and quantifying drug delivery in skin – Part 2: Fluorescence andvibrational spectroscopic imaging methods
|Advanced Drug Delivery Reviews|2020|64